Return to Article Details
COST-EFFECTIVENESS EVALUATION OF BRENTUXIMAB VEDOTIN IN TREATING CLASSICAL HODGKIN LYMPHOMA PATIENT RELAPSED/PROGRESSED POST AUTOLOGOUS STEM CELL TRANSPLANT
Download
Download PDF